false 0001017303 false false false false 0001017303 2024-11-07 2024-11-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 7, 2024

 

 

 

TransAct Technologies Incorporated

(Exact name of registrant as specified in its charter)

 

 

Delaware 0-21121 06-1456680
(State or other jurisdiction of incorporation) (Commission file number) (I.R.S. employer identification no.)

 

One Hamden Center  
2319 Whitney Ave, Suite 3B, Hamden, CT 06518
(Address of principal executive offices) (Zip Code)

 

Registrant's telephone number, including area code: (203) 859-6800

 

(Former Name or Former Address, if Changed Since Last Report): Not applicable

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, par value $.01 per share TACT NASDAQ Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

  
 

 

Item 2.02 Results of Operations and Financial Condition.

 

The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K.  Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

On November 7, 2024, TransAct Technologies Incorporated issued a press release announcing its preliminary financial results for the quarter ended September 30, 2024.  A copy of the press release is furnished as Exhibit 99.1 to this report.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit   Description
99.1   Press Release dated November 7, 2024 of TransAct Technologies Incorporated
104   Cover page from this Current Report on Form 8-K, formatted in Inline XBRL

 

  
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  TRANSACT TECHNOLOGIES INCORPORATED
     
  By: /s/ Steven A. DeMartino
    Steven A. DeMartino
    President, Chief Financial Officer, Treasurer and Secretary

 

Date: November 7, 2024

 

 

 

 

 

 

Exhibit 99.1

 

 

 

TransAct Technologies Reports Preliminary Third Quarter 2024 Financial Results

Sold Over 1,350 Terminals in the Quarter, With Over 2,800 Sold in the Last Two Quarters

 

Added 12 New FST Customers in the Quarter

 

Casino Market Continues to Normalize after Industry Inventory Build During Pandemic

 

 

 

 

Hamden, CT – November 7, 2024 – TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”), a global leader in software-driven technology and printing solutions for high-growth markets, today reported preliminary results for the third quarter ended September 30, 2024.

 

“We reported an excellent FST quarter, with another 1,355 BOHA! Terminal sales. We believe this momentum is just the beginning, with the effects of our re-organization and re-focusing of the sales team and go-to-market process starting to yield positive results,” said John Dillon, Chief Executive Officer of TransAct. “We also added another 12 new FST accounts in the quarter, representing approximately 2,400 potential Terminal 2 sales opportunities. Our pipeline continues to hold strong under continued scrubbing, and as we further refine our process, we expect to further improve our go-to-market execution and generate improving conversion rates in 2025.”

 

Third Quarter 2024 Financial Highlights

 

Net Sales: Net sales for the third quarter of 2024 were $10.9 million, down 6% sequentially and down 37% compared to $17.2 million for the third quarter of 2023, largely as a result of the expected market dynamics and normalizing demand for our Casino and Gaming printers.

 

FST Recurring Revenue: FST recurring revenue for the third quarter of 2024 was $2.9 million, which was up 4% sequentially, but down 8% compared to $3.1 million for the third quarter of 2023.

 

Gross Profit: Gross profit for the third quarter of 2024 was $5.2 million, resulting in gross margin of 48.1%, compared to gross profit of $8.9 million for the third quarter of 2023, which delivered a 51.9% gross margin.

 

Operating (loss) income: Operating loss for the third quarter of 2024 was $(837) thousand, compared to an operating loss of $(438) thousand for the second quarter of 2024 and operating income of $1.2 million for the third quarter of 2023.

 

Net (loss) income: Net loss for the third quarter of 2024 was $(551) thousand, or $(0.06) per diluted share, based on 10.0 million weighted average common shares outstanding, compared sequentially to a net loss for the second quarter of 2024 of $(319) thousand, or $(0.03) per diluted share.
This compares to net income for the third quarter of 2023 of $906 thousand, or $0.09 per diluted share, based on 10.1 million weighted average common shares outstanding.

 

EBITDA: EBITDA was negative $(533) thousand for the third quarter of 2024, compared to negative $(190) thousand for the second quarter of 2024 and $1.5 million for the third quarter of 2023.

 

Adjusted EBITDA: Adjusted EBITDA was negative $(204) thousand for the third quarter of 2024, compared to $89 thousand in the second quarter of 2024, and $1.7 million for the third quarter of 2023.

 

  
 

 

Updated 2024 Financial Outlook

 

Net Sales: The Company now expects full year 2024 net sales of between $43 million and $45 million.

 

Adjusted EBITDA: The Company continues to expect full year 2024 adjusted EBITDA to be between negative $1 million and negative $2 million

 

Our outlook for non-GAAP adjusted EBITDA is presented only on a non-GAAP basis because not all of the information necessary for a quantitative reconciliation of this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure is available without unreasonable effort, primarily due to uncertainties relating to the occurrence or amount of these adjustments that may arise in the future. If one or more of the currently unavailable items is applicable, some items could be material, individually or in the aggregate, to GAAP reported results. 

 

Strategic Business Review

 

The Company continues to actively assess strategic alternatives with the assistance of Roth Capital Partners, LLC, the Company’s advisor while continuing to pursue its business growth and development initiatives on a parallel track. The Company has engaged with a number of outside parties since the previous update in June and is in various stages of discussion with such outside parties. The Company is committed to pursuing an optimal outcome for all its stakeholders and maximizing shareholder value. 

 

2024 Third Quarter Conference Call and Webcast

TransAct is hosting a conference call and webcast today, November 7, 2024, beginning at 4:30 p.m. ET to discuss the Company’s preliminary third quarter 2024 results and other matters. Both the call and the webcast are open to the general public. The conference call number is 877-704-4453 and the conference ID number is 13749888. Please call ten minutes prior to the presentation to ensure that you are connected.

 

Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Company” followed by “Investor Relations,” then select “News & Events” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.

 

Non-GAAP Financial Measures

TransAct is providing certain non-GAAP financial measures because the Company believes that these measures are helpful to investors and others in assessing the ongoing nature of what the Company’s management views as TransAct’s core operations. EBITDA and adjusted EBITDA provide the Company with an understanding of one aspect of earnings before the impact of investing and financing charges and income taxes. The Company believes that these non-GAAP financial measures provide relevant and useful information to an investor evaluating the Company’s operating performance because these measures are: (i) widely used by investors to measure a company’s operating performance without regard to items that do not reflect the Company’s ongoing operations and are excluded from the calculation of such measures; (ii) used as financial measurements by lenders and other parties to evaluate creditworthiness; and (iii) used by the Company’s management for various purposes including strategic planning and forecasting and assessing financial performance. Adjusted net (loss) income and adjusted net (loss) income per diluted share provide the Company with an understanding of the results of the primary operations of the business by excluding the effects of special items (for example, the $1.5 million severance charge related to the resignation of the Company’s former CEO in the first nine months of 2023) that do not reflect the ordinary earnings of the Company’s operations. The Company uses these measures to evaluate period-over-period operating performance because the Company believes this provides a more comparable measure of the Company’s continuing business, as these measures adjust for the special items that are not reflective of the normal results of the business. The presentation of this non-GAAP information is not considered superior to or a substitute for, and should be read in conjunction with, the financial information prepared in accordance with GAAP.

 

  
 

 

EBITDA is defined as net (loss) income before net interest income (expense), income taxes, depreciation, and amortization. A reconciliation of EBITDA to net (loss) income, the most comparable GAAP financial measure, can be found attached to this release.

 

Adjusted EBITDA is defined as net (loss) income before net interest income (expense), income taxes, depreciation and amortization and is adjusted for (1) share-based compensation expense, (2) the $1.5 million severance charge related to the resignation of the Company’s former CEO in the first nine months of 2023 and (3) any other items, when they occur, that we believe do not reflect the ordinary earnings of the Company’s ongoing business. The Company adjusts EBITDA for share-based compensation because the Company considers share-based compensation expense to be a non-cash expense similar to depreciation and amortization. A reconciliation of adjusted EBITDA to net (loss) income, the most comparable GAAP financial measure, can be found attached to this release.

 

Adjusted net (loss) income is defined as net (loss) income adjusted for the $1.5 million severance charge related to the resignation of the Company’s former CEO in the first nine months of 2023. A reconciliation of adjusted net (loss) income to net (loss) income, the most comparable GAAP financial measure, can be found attached to this release.

 

Adjusted net (loss) income per diluted share is defined as adjusted net (loss) income divided by diluted shares outstanding. A reconciliation of adjusted net (loss) income per diluted share to net (loss) income per diluted share, the most comparable GAAP financial measure, can be found attached to this release.

 

About TransAct Technologies Incorporated

TransAct Technologies Incorporated is a global leader in developing and selling software-driven technology and printing solutions for high-growth markets including food service, casino and gaming, and POS automation. The Company’s solutions are designed from the ground up based on customer requirements and are sold under the BOHA!™, AccuDate™, EPICENTRAL®, Epic and Ithaca® brands. TransAct has sold over 3.9 million printers, terminals and other hardware devices around the world and is committed to providing world-class service, spare parts, and accessories to support its installed product base. Through the TransAct Services Group, the Company also provides customers with a complete range of supplies and consumable items both online at http://www.transactsupplies.com and through its direct sales team. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call (203) 859-6800.

 

©2024 TRANSACT Technologies Incorporated. All rights reserved. TransAct®, BOHA!™, AccuDate™, Epic Edge®, EPICENTRAL® and Ithaca® are trademarks of TransAct Technologies Incorporated.

 

Cautionary Statement Regarding Preliminary Financial Information

The Company has prepared the preliminary financial information set forth below on a materially consistent basis with its historical financial information and in good faith based upon its internal reporting as of and for the three and nine months ended September 30, 2024. This financial information is preliminary and is thus inherently uncertain and subject to change as the Company finalizes its financial results and related review for the three and nine months ended September 30, 2024. During the course of the preparation of the Company’s condensed consolidated financial statements and related notes as of and for the three and nine months ended September 30, 2024, the Company may identify items that could cause its final reported results to be materially different from the preliminary financial information set forth above. As a result, there can be no assurance that the Company’s final results for this period will not differ from the preliminary financial information.

 

  
 

 

This preliminary financial information should not be viewed as a substitute for full financial statements prepared in accordance with GAAP. In addition, this preliminary financial information is not necessarily indicative of the results to be achieved for any future period.

 

Forward-Looking Statements

Certain statements included in this press release may be forward-looking statements within the meaning of the U.S. federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward-looking statements are any statements other than statements of historical fact. Forward-looking statements represent current views about possible future events and are often identified by the use of forward-looking terminology, such as ”may”", ”will”, ”could”, ”expect”, ”intend”, ”estimate”, “anticipate”, ”believe”, ”project”, ”plan”, ”predict”, ”design” or ”continue”, or the negative thereof, or other similar words. Forward-looking statements are subject to certain risks, uncertainties and assumptions. In the event that one or more of such risks or uncertainties materialize, or one or more underlying assumptions prove incorrect, actual results may differ materially from those expressed or implied by the forward-looking statements. Important factors and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements include, but are not limited to, the following: the adverse effects of current economic conditions on our business, operations, financial condition, results of operations and capital resources; difficulties or delays in manufacturing or delivery of inventory or other supply chain disruptions; inflationary pressures; the Russia/Ukraine and Middle East conflicts; inadequate manufacturing capacity or a shortfall or excess of inventory as a result of difficulty in predicting manufacturing requirements due to volatile economic conditions; price increases or decreased availability of third party component parts or raw materials at reasonable prices; our ability to successfully develop new products that garner customer acceptance and generate sales, both domestically and internationally, in the face of substantial competition; our reliance on an unrelated third party to develop, maintain and host certain web-based food service application software and develop and maintain selected components of our downloadable software applications pursuant to a non-exclusive license agreement, and the risk that interruptions in our relationship with that third party could materially impair our ability to provide services to our food service technology customers on a timely basis or at all and could require substantial expenditures to find or develop alternative software products; any system outages, interruptions or other disruptions to our software applications, including as a result of unexpected errors or mistakes in connection with over-the-air updates; our ability to successfully grow our business in the food service technology market; risks associated with the pursuit of strategic initiatives and business growth; our dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our dependence on significant suppliers; our ability to recruit and retain quality employees; our dependence on third parties for sales outside the United States; marketplace acceptance of new products; risks associated with foreign operations; price wars, or other significant pricing pressures affecting the Company’s products in the United States or abroad; increased product costs or reduced customer demand for our products due to changes in U.S. policy that may result in trade wars or tariffs; political and policy uncertainties in connection with the U.S. presidential election; our ability to protect intellectual property; exchange rate fluctuations; the availability of needed financing on acceptable terms or at all; volatility of, and decreases in, trading prices of our common stock; and other risk factors identified and discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and other reports filed with the Securities and Exchange Commission. We caution readers not to place undue reliance on forward-looking statements, which speak only as of the date of this release. We undertake no obligation to publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or other factors, except where we are expressly required to do so by applicable law.

# # #

 

Investor Contact:

Ryan Gardella

ICR, Inc.

Ryan.Gardella@icrinc.com

 

- Financial tables follow-

 

  
 

 

TRANSACT TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Preliminary and Unaudited)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
   (In thousands, except per share data) 
                 
Net sales  $10,867   $17,190   $33,153   $59,366 
Cost of sales   5,640    8,274    16,192    27,337 
Gross profit   5,227    8,916    16,961    32,029 
                     
Operating expenses:                    
Engineering, design and product development   1,640    2,509    5,405    7,283 
Selling and marketing   1,880    2,397    6,160    7,838 
General and administrative   2,544    2,819    7,972    10,680 
    6,064    7,725    19,537    25,801 
Operating (loss) income   (837)   1,191    (2,576)   6,228 
                     
Interest and other income (expense):                    
Interest, net   42    (73)   116    (207)
Other, net   96    (43)   43    (22)
    138    (116)   159    (229)
                     
(Loss) income before income taxes   (699)   1,075    (2,417)   5,999 
Income tax benefit (expense)   148    (169)   511    (1,189)
Net (loss) income  $(551)  $906   $(1,906)  $4,810 
                     
Net (loss) income per common share:                    
Basic  $(0.06)  $0.09   $(0.19)  $0.48 
Diluted  $(0.06)  $0.09   $(0.19)  $0.48 
                     
Shares used in per share calculation:                    
Basic   10,006    9,958    9,992    9,948 
Diluted   10,006    10,052    9,992    10,023 

 

  
 

 

SUPPLEMENTAL INFORMATION – SALES BY MARKET:

(Preliminary and Unaudited) 

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
   (In thousands) 
                 
Food service technology  $4,321   $4,241   $11,799   $11,594 
POS automation   1,148    1,644    2,950    5,345 
Casino and gaming   4,534    9,019    15,589    37,002 
TransAct Services Group   864    2,286    2,815    5,425 
Total net sales  $10,867   $17,190   $33,153   $59,366 

 

  
 

 

TRANSACT TECHNOLOGIES INCORPORATED

CONDENSED CONSOLIDATED BALANCE SHEETS

(Preliminary and Unaudited)

 

   September 30,   December 31, 
   2024   2023 
   (In thousands) 
Assets:        
Current assets:          
Cash and cash equivalents  $11,343   $12,321 
Accounts receivable, net   7,421    9,824 
Inventories   16,851    17,759 
Prepaid income taxes   713    322 
Other current assets   1,079    773 
Total current assets   37,407    40,999 
           
Fixed assets, net   1,986    2,421 
Right-of-use assets, net   1,380    1,602 
Goodwill   2,621    2,621 
Deferred tax assets   7,034    6,304 
Intangible assets, net   -    88 
Other assets   75    163 
    13,096    13,199 
Total assets  $50,503   $54,198 
           
Liabilities and Shareholders’ Equity:          
Current liabilities:          
Revolving loan payable  $2,250   $2,250 
Accounts payable   3,210    4,431 
Accrued liabilities   3,883    4,947 
Lease liabilities   983    929 
Deferred revenue   926    1,079 
Total current liabilities   11,252    13,636 
           
Deferred revenue, net of current portion   240    209 
Lease liabilities, net of current portion   438    720 
Other liabilities   219    219 
    897    1,148 
Total liabilities   12,149    14,784 
           
Shareholders’ equity:          
Common stock   141    140 
Additional paid-in capital   57,857    57,055 
Retained earnings   12,472    14,378 
Accumulated other comprehensive loss, net of tax   (6)   (49)
Treasury stock, at cost   (32,110)   (32,110)
Total shareholders’ equity   38,354    39,414 
Total liabilities and shareholders’ equity  $50,503   $54,198 

 

  
 

 

TRANSACT TECHNOLOGIES INCORPORATED

RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING

NON-GAAP FINANCIAL MEASURES

(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts)

 

   Three months ended
September 30, 2024
 
   Reported  

 

Adjustments(1)

   Adjusted
Non-GAAP
 
Operating expenses  $6,064   $-   $6,064 
% of net sales   55.8%        55.8%
                
Operating loss   (837)   -    (837)
% of net sales   (7.7)%        (7.7)%
                
Interest and other income   138    -    138 
Loss before income taxes   (699)   -    (699)
Income tax benefit   148    -    148 
Net loss   (551)   -    (551)
Net loss per common share:               
Basic  $(0.06)  $-   $(0.06)
Diluted  $(0.06)  $-   $(0.06)

  

(1)No adjustments.

 

 

   Three months ended
September 30, 2023
 
   Reported  

 

Adjustments(2)

   Adjusted
Non-GAAP
 
Operating expenses  $7,725   $-   $7,725 
% of net sales   44.9%        44.9%
                
Operating income   1,191    -    1,191 
% of net sales   6.9%        6.9%
                
Interest and other expense   (116)   -    (116)
Income before income taxes   1,075    -    1,075 
Income tax (expense)   (169)   -    (169)
Net income   906    -    906 
Net income per common share:               
Basic  $0.09   $-   $0.09 
Diluted  $0.09   $-   $0.09 

  

(2)No adjustments.

 

  
 

 

TRANSACT TECHNOLOGIES INCORPORATED

RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING

NON-GAAP FINANCIAL MEASURES

(Preliminary and Unaudited, thousands of dollars, except percentages and per share amounts) 

 

   Nine months ended
September 30, 2024
 
   Reported  

 

Adjustments(3)

   Adjusted
Non-GAAP
 
Operating expenses  $19,537   $-   $19,537 
% of net sales   58.9%        58.9%
                
Operating loss   (2,576)   -    (2,576)
% of net sales   (7.8)%        (7.8)%
                
Interest and other income   159    -    159 
Loss before income taxes   (2,417)   -    (2,417)
Income tax benefit   511    -    511 
Net loss   (1,906)   -    (1,906)
Net loss per common share:               
Basic  $(0.19)  $-   $(0.19)
Diluted  $(0.19)  $-   $(0.19)

 

(3)No adjustments.

 

 

   Nine months ended
September 30, 2023
 
   Reported  

 

Adjustments(4)

   Adjusted
Non-GAAP
 
Operating expenses  $25,801   $(1,461)  $24,340 
% of net sales   43.5%        41.0%
                
Operating income   6,228    1,461    7,689 
% of net sales   10.5%        13.0%
                
Interest and other expense   (229)   -    (229)
Income before income taxes   5,999    1,461    7,460 
Income tax (expense)   (1,189)   (70)   (1,259)
Net income   4,810    1,391    6,201 
Net income per common share:               
Basic  $0.48   $0.14   $0.62 
Diluted  $0.48   $0.14   $0.62 

  

(4)Adjustment includes a severance charge of $1,461 incurred in April 2023 related to the resignation of the Company’s former CEO.

 

  
 

 

TRANSACT TECHNOLOGIES INCORPORATED

RECONCILIATION OF NET (LOSS) INCOME TO EBITDA AND ADJUSTED EBITDA

NON-GAAP FINANCIAL MEASURES

(Preliminary and Unaudited)

 

   Three months ended   Nine months ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
   (In thousands) 
                 
Net (loss) income  $(551)  $906   $(1,906)  $4,810 
                     
Interest (income) expense, net   (42)   73    (116)   207 
Income tax (benefit) expense   (148)   169    (511)   1,189 
Depreciation and amortization   208    381    844    1,103 
                     
EBITDA   (533)   1,529    (1,689)   7,309 
                     
Share-based compensation expense   329    213    873    611 
Severance charge related to resignation of the Company’s former CEO   -    -    -    1,461 
                     
Adjusted EBITDA  $(204)  $1,742   $(816)  $9,381